486 related articles for article (PubMed ID: 31776090)
1. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
Nosrati M; Mohabatkar H; Behbahani M
Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
3. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
[TBL] [Abstract][Full Text] [Related]
4. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
[TBL] [Abstract][Full Text] [Related]
5. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
6. Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.
Nosrati M; Behbahani M; Mohabatkar H
J Biomed Inform; 2019 May; 93():103160. PubMed ID: 30928513
[TBL] [Abstract][Full Text] [Related]
7. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
[TBL] [Abstract][Full Text] [Related]
8. Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.
Fritzen A; Risinger C; Korukluoglu G; Christova I; Corli Hitzeroth A; Viljoen N; Burt FJ; Mirazimi A; Blixt O
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006598. PubMed ID: 29985929
[TBL] [Abstract][Full Text] [Related]
9. Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus.
Moming A; Tuoken D; Yue X; Xu W; Guo R; Liu D; Li Y; Hu Z; Deng F; Zhang Y; Sun S
PLoS One; 2018; 13(9):e0204264. PubMed ID: 30235312
[TBL] [Abstract][Full Text] [Related]
10. Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach.
Burt FJ; Samudzi RR; Randall C; Pieters D; Vermeulen J; Knox CM
J Virol Methods; 2013 Nov; 193(2):706-12. PubMed ID: 23933073
[TBL] [Abstract][Full Text] [Related]
11. Computational Prediction of Usutu Virus E Protein B Cell and T Cell Epitopes for Potential Vaccine Development.
Palanisamy N; Lennerstrand J
Scand J Immunol; 2017 May; 85(5):350-364. PubMed ID: 28273384
[TBL] [Abstract][Full Text] [Related]
12. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping epitope on glycoprotein-Gn from Crimean-Congo hemorrhagic fever virus.
Shalitanati A; Yu H; Liu D; Xu WX; Yue X; Guo R; Li Y; Deng F; Yang J; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():24-31. PubMed ID: 30290884
[TBL] [Abstract][Full Text] [Related]
14. Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection.
Goedhals D; Paweska JT; Burt FJ
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006149. PubMed ID: 29261651
[TBL] [Abstract][Full Text] [Related]
15. Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of
Elamin Elhasan LM; Hassan MB; Elhassan RM; Abdelrhman FA; Salih EA; Ibrahim H A; Mohamed AA; Osman HS; Khalil MSM; Alsafi AA; Idris AB; Hassan MA
J Immunol Res; 2021; 2021():8280925. PubMed ID: 34036109
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatic Analysis of Crimean Congo Hemorrhagic Fever Virus Glycoproteins and Epitope Prediction for Synthetic Peptide Vaccine.
Tipu HN
J Coll Physicians Surg Pak; 2016 Feb; 26(2):108-12. PubMed ID: 26876396
[TBL] [Abstract][Full Text] [Related]
17. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.
Omoniyi AA; Adebisi SS; Musa SA; Nzalak JO; Bauchi ZM; Bako KW; Olatomide OD; Zachariah R; Nyengaard JR
Sci Rep; 2022 May; 12(1):8736. PubMed ID: 35610299
[TBL] [Abstract][Full Text] [Related]
18. In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever.
Baral P; Pavadai E; Gerstman BS; Chapagain PP
Sci Rep; 2020 May; 10(1):7667. PubMed ID: 32376973
[TBL] [Abstract][Full Text] [Related]
19. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
[TBL] [Abstract][Full Text] [Related]
20. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
